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Abstract
B cells alter the expression of immunoglobulin isotypes through a process known as class switch
recombination (CSR). In these cells, activation induced cytidine deaminase (AID) binds Gquadruplex (G4) switch transcripts, which serve as guide RNAs to target AID to the
immunoglobulin heavy chain switch (S) regions in the DNA for CSR. Sequence alignment
revealed homology between the AID G4 binding domain and the RNA helicase associated with
AU-rich element (RHAU) specific motif (RSM), which allows RHAU binding to G4 RNAs and
subsequent unwinding of G4 RNA into single-stranded transcripts. We hypothesize that RHAU
functions in CSR by binding G4 S transcripts and resolving them into linear transcripts which
base pair with the immunoglobulin heavy chain S region DNA to localize AID specifically to the
recombining S regions. To test this hypothesis, we conditionally deleted floxed Rhau alleles in
mouse B cells using a CD23-cre transgene. RhauD/D B cells show decreased in vitro CSR to IgG1
and RhauD/D mice display decreased IgG1, IgA, and IgG3 titers, suggesting that RHAU regulates
CSR.
Introduction
Organisms such as humans and mice can mount a specific and lasting immunity against
individual pathogens with the help of T cells and B cells of the adaptive immune system
(Murphy et al., 2008). T cells mediate cellular immunity as they can directly kill infected cells
and activate other immune cells, while B cells mediate humoral immunity through the
production and secretion of proteins known as antibodies (Murphy et al., 2008). The latter can
neutralize pathogens, allowing them to be destroyed by other components of the immune
system (Murphy et al., 2008). Antibodies, which are scientifically known as immunoglobulins
(Igs), are composed of four polypeptide chains, two light chains and two heavy chains that are
joined by disulfide bonds. The amino-terminus of an Ig contains the variable region, while the
carboxyl-terminus of the Ig contains the constant region (Murphy et al., 2008). The constant
portion of the Ig heavy chain (IgH) determines the Ig effector function and Ig isotype, which
includes, IgM, IgD, IgG, IgA, and IgE that are encoded by Cµ, Cδ, Cγ, Cα, and Cε, respectively
(Murphy et al., 2008).
Following their development in the bone marrow, B cells migrate to secondary lymphoid organs
such as the spleen, lymph nodes, and Peyer’s patches where they encounter antigens
(Matthews et al., 2014; Murphy et al., 2008). After presenting antigens to helper T cells and
receiving co-stimulation from these T cells, the B cells become activated and switch from
expressing IgM and IgD to expressing one of the other isotypes in a process known as class
switch recombination (CSR) (Matthews et al., 2014; Murphy et al., 2008). The Ig expressed after
CSR has a new effector function, while retaining the same specificity for the antigen, which is
determined by the variable region (Matthews et al., 2014; Murphy et al., 2008). At the DNA
level, CSR is initiated by activation induced cytidine deaminase (AID), which deaminates cytidine
residues at specific regions of the immunoglobulin heavy (IgH) chain genes known as switch (S)
regions (Chaudhuri et al., 2003; Muramatsu et al., 2000). These S regions precede the constant
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region (CH) gene segments that code for the IgH constant regions (Chaudhuri et al., 2003;
Muramatsu et al., 2000). During CSR, AID deaminates cytidine residues at the Sµ region
preceding the Cµ gene segment and one of the downstream S regions (Matthews et al., 2014).
Deamination of cytidines converts them into uridines, creates mismatches in the DNA, and
activates components of the base excision repair (BER) and mismatch repair (MMR) pathways.
The non-canonical repair mechanisms introduce DNA double strand breaks (DSBs) and the
subsequent excision of the DNA fragment between the breaks (Matthews et al., 2014). The
donor Sµ region is ligated to the downstream acceptor S region, juxtaposing a new C H gene
segment downstream of the variable VDJ segment to express a new Ig isotype (Matthews et al.,
2014).
Germline transcription through the CH exons precedes CSR (Stavnezer-Nordgren & Sirlin, 1986;
Shinkura et al,. 2003). Each CH gene segment is organized into individual transcription units
composed of a promoter activated by specific cytokines, I exons, intronic S regions, and CH
exons (Honjo & Kataoka, 1978; Xu & Stavnezer, 1990). Each transcription unit produces a
primary germline transcript, which is spliced to release the intronic S transcript as a lariat and
the noncoding mature germline transcript from the joining of the I exon with the CH exons (Xu
& Stavnezer, 1990). The intronic S transcript is rich in guanine residues which base pair with
each other to form a four-stranded RNA transcript known as G-quadruplex or G4 transcript
(Matthews et al., 2014; Zheng et al., 2015). AID has a high affinity for these G4 S transcripts,
which serve as guide RNAs to target AID to the switch regions in the B cell DNA in a sequence
specific manner (Zheng et al., 2015). Glycine 133 (G133) of AID is important for the interaction
of AID with the G4 S transcripts (Zheng et al., 2015). Consistent with this, a G133V mutation in
AID disrupts its interaction with the S transcripts, completely abolishes CSR, and causes hyperIgM syndrome (Zheng et al., 2015; Mahdaviani et al., 2012). Sequence alignment revealed
homology between the G4 binding domain of AID and the RNA-binding domain of the well
characterized RNA helicase associated with AU-rich element (RHAU), also known as DHX36
(Lattmann et al., 2010). G133 of AID is conserved in the RHAU specific motif (RSM), which is in
the amino-terminal region of RHAU (Lattmann et al., 2010; Zheng et al., 2015) and allows RHAU
to bind and resolve G4 structures in RNAs (Booy et al., 2012; Lattmann et al., 2010; Sauer et al.,
2019). These observations led us to hypothesize that RHAU may also bind the G4 S transcripts
to unwind them and promote base pairing of the S transcripts with the S region DNA to target
AID for CSR. To test this hypothesis, we genetically deleted Rhau specifically in mouse B cells
because germline deletion of Rhau results in embryonic lethality from defective hematopoiesis,
spermatogonia differentiation, and embryonic heart development (Lai et al., 2012; Gao et al.,
2015; Jiang et al., 2021). In this research study we show that conditional knockout of Rhau in
mouse B cells using the Cre-LoxP system decreases CSR in vitro and in vivo.

3

Materials and Methods
Generation of Mice
The cre gene was inserted in the Aid locus to obtain Aidcre/+ mice (Robbiani et al., 2008). Knockin mice containing the Rhau floxed alleles (RhauF/F) were generated as previously described (Lai
et al., 2012). B cell-specific deletion of Rhau in mice was achieved by crossing Aidcre/+ mice with
RhauF/F mice to generate Aidcre/+RhauF/+ offspring. Aidcre/+RhauF/+ mice were subsequently
backcrossed with RhauF/F mice to obtain Aidcre/+RhauF/F mice (Jiang et al., 2021). CD23-cre+
transgenic mice were generated as previously described (Kwon et al., 2008), and were crossed
with RhauF/F mice to generate CD23-cre+RhauF/+ mice. The latter were backcrossed with RhauF/F
mice to generate CD23-cre+RhauF/F mice.
In vitro class switch recombination assay
Mature B cells were harvested from mouse spleens. B cells were negatively selected using antiCD43 magnetic beads. In a 10-cm dish, B cells were cultured at a density of 10x106 cells/mL in
10mL B cell media (RPMI with HEPES, 10% FBS, 2 mM L-glutamine, 1X penicillin/streptomycin,
and 47.3M beta-mercaptoethanol) and stimulated to switch to IgG1 with 25µg/mL
lipopolysaccharide (LPS) and 12.5ng/mL interleukin-4 (IL-4) (Choi et al., 2019). The B cells were
passaged 1:2 at 48 hours and 72 hours post-stimulation. The cells were stained with anti-IgG1
conjugated to allophycocyanin (APC) (1:1000) diluted in FACS buffer (PBS pH 7.4 supplemented
with 2.5% of FBS), and 10mg/mL DAPI (1:500) diluted in FACS buffer at 96 hours poststimulation for flow cytometry (Choi et al., 2019; Sible et al., 2021). The B cells were analyzed
on an LSRII flow cytometer. Unstained, DAPI single stained (DAPIss), and APC single stained
(APCss) controls were used to set the gates for the live B cells positive for IgG1. Flowjo was used
to analyze the flow cytometry data. P-values were calculated in GraphPad Prism using twotailed student t test to compare the amount of IgG1-positive B cells between the different
genotypes.
Polymerase chain reaction (PCR) genotyping reactions
Rhau-forward (TGT ACA TTT TGA TAC TAC TTA ATC TAC CCT TTG A) and Rhau-reverse (TAT GGA
AAT GCT CCT AGT TAA AGT TTA GAG CT) primers were used to detect the Rhau WT, floxed, and
deleted alleles with PCR products of 2.6kb, 2.2kb, and 1.5kb, respectively (Lai et al., 2012).
CD23cre_1 (GCG ACT AGT AAC TTG TTT ATT GCA GCT TAT) and CD23cre_2 (GCG TCC GGA AGA
CAC CAC ATC CCA ATT CTT) primers were used to amplify the CD23-cre allele to produce a
~600bp PCR product.
Analysis of serum immunoglobulins
Briefly, mice were injected intraperitoneally with 50µg 4-Hydroxy-3-nitrophenylacetyl
conjugated to chicken gamma globulin (NP-CGG, 100µL) in alum (100µL) on day 0. The mice
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received a NP-CGG booster immunization on day 10. Sera were collected through cheek bleeds
of the submandibular vein on day 0 before immunization and on day 7. Terminal bleeds were
collected through the vena cava on day 21 following the first immunization. Ig titers were
measured on anti-IgM, anti-IgG1, anti-IgA, and anti-IgG3 96-well-coated plates. Serum samples
were prepared over eight-step 1:2 dilution series as follow: on day 0, CD23-cre+RhauF/+ and
RhauF/F sera were diluted starting at 1:5,000 for IgM and IgG1 titers, 1:10,000 for IgA titers, and
1:1,000 for IgG3 titers. CD23-cre+RhauF/F sera were diluted on day 0 starting at 1:10,000 for IgM
titers, and 1:1,000 for IgG1, IgA, and IgG3 titers. On day 7 CD23-cre+RhauF/+ and RhauF/F sera
were diluted starting at 1:10,000 for IgM and IgA titers, 1:5,000 for IgG1 titers, and 1:1,000 for
IgG3 titers. CD23-cre+RhauF/F sera were diluted on day 7 starting at 1:10,000 for IgM titers,
1:500 for IgG1 titers, 1:1,000 for IgA and IgG3 titers. On day 21 CD23-cre+RhauF/+ and RhauF/F
sera were diluted starting at 1:10,000 for IgM, IgG1, IgA titers, and 1:5,000 for IgG3 titers.
CD23-cre+RhauF/F sera were diluted on day 21 starting at 1:10,000 for IgM titers, 1:5,000 for
IgG1 and IgA titers, and 1:2,000 for IgG3 titers. Titers were detected using anti-IgM-HRP, antiIgG1-HRP, anti-IgA-HRP, and anti-IgG3-HRP. The plates were developed with 50µL of TMB
added to each well, followed by 50µL of 1 M phosphoric acid to stop the development.
Absorbance for the standards and samples were measured at 450nm (A450). To quantify the Ig
concentrations, A450 for the blanks were averaged and subtracted from the A450 of the
standards and diluted serum. Duplicates for the standards and samples were averaged, a linear
standard curve was generated (R² ≥ 0.95), and data outside of the standard curve were
discarded. Ig concentrations for each dilution within the standard curve were calculated and
averaged.
Results
Aidcre/+RhauF/F B cells show in vitro CSR comparable to wild type B cells
Germline deletion of Rhau in mice results in embryonic lethality (Lai et al., 2012). To investigate
whether RHAU plays a role in CSR, we used the Cre-loxP system to specifically delete Rhau in
mouse B cells. In this system, a Cre recombinase is under the control of the B cell-specific
promoter Aid, and two LoxP sequences flank exon 8 of Rhau, which codes for 27 amino acids of
the helicase core domain of RHAU (Lai et al., 2012; Lattmann et al., 2010). Activation of the Aid
promoter in B cells induces the expression of Cre recombinase, which excises the two loxP sites
that flank exon 8 of Rhau, introduces a premature stop codon, and activates nonsensemediated mRNA decay, leading to loss of RHAU expression (Lai et al., 2012). We examined CSR
in B cells purified from Aidcre/+RhauF/F mice and control mice (RhauF/+, RhauF/F, Aidcre/+,
Aidcre/+RhauF/+, and wild type (WT)). The B cells were stimulated to switch in vitro to IgG1 with
LPS and IL-4. The cells were cultured for 96 hours and stained with anti-IgG1 conjugated to APC.
In our fluorescence-activated single cell sorting (FACS) analysis, we predicted the deletion of
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Rhau in the Aidcre/+RhauF/F B cells would decrease CSR to IgG1. However, we observed an
average of 15% IgG1 in Aidcre/+RhauF/F B cells, which was within the range of WT CSR and
comparable to CSR observed in the RhauF/F, RhauF/+, and Aidcre/+ control cells (Fig. 1A, 1B,
Appendix Fig. 1). The WT CSR observed in the Aidcre/+RhauF/F B cells suggested the lack of Rhau
deletion in Aidcre/+RhauF/F B cells, which may result from inefficient expression of Cre by the Aid
promoter and consequently ineffective deletion of the floxed Rhau alleles.

Figure 1. WT CSR to IgG1 in Aidcre/+RhauF/F B cells
(A) Aidcre/+RhauF/F B cells show similar CSR to IgG1 as compared to control cells. For wild type (WT)
(n=1), Aidcre/+ (n=1), RhauF/+ (n=2), Aidcre/+ RhauF/+ (n=4), RhauF/F (n=4), and Aidcre/+RhauF/F (n=4).
(B) Aggregated data shows comparable average CSR to IgG1 between the Aidcre/+RhauF/F B cells and
the control B cells (RhauF/F, Aidcre/+RhauF/+). Each black dot represents B cells purified from a single
mouse.

Decreased in vitro CSR to IgG1 in CD23-cre+RhauF/F B cells
To determine whether cre expression under the control of another promoter could efficiently
delete Rhau, we bred the RhauF/F mice to CD23-cre+ transgenic mice (Kwon et al., 2008). CD23
is constitutively expressed in mature B cells (Carsetti et al., 1995), unlike AID which is only
expressed when B cells are stimulated for CSR or somatic hypermutation (Muramatsu et al.,
1999). We therefore expected the CD23 promoter to drive the expression of Cre recombinase
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and the deletion of the RhauF/F alleles in the CD23-cre+RhauF/F B cells before the cells are
stimulated for CSR in vitro. We observed 20.2%, and 19.7% CSR to IgG1 for the CD23cre+RhauF/+ and RhauF/F control cells, respectively (Fig. 2). CSR to IgG1 observed in the CD23cre+RhauF/+and RhauF/F control cells was within the 15-30% range of WT B cell CSR (Choi et al.,
2019). We observed CSR to IgG1 between 6% and 10% in the CD23-cre+RhauF/F B cells, which
was 2-fold lower than the switching observed in the CD23-cre+RHAUF/+ and RHAUF/F control cells
(20.2% and 19.7%, respectively) (Fig. 2, Appendix Fig. 2, Appendix Fig. 3).

Figure 2. Reduced in vitro CSR to IgG1 in CD23-cre+RhauF/F B cells.
A representative flow cytometry analysis of B cells of the indicated genotypes showing percentage of
IgG1 positive B cells in the boxed gate.

To determine whether the decreased in vitro CSR to IgG1 in the CD23-cre+RhauF/F B cells was
specifically due to the deletion of the RhauF/F alleles, we isolated genomic DNA from the
LPS+IL4-stimulated B cells and used PCR primers to amplify the Rhau WT, floxed, and deleted
alleles. We detected the deleted Rhau alleles at 1.5kb in the CD23-cre+RhauF/F and CD23cre+RhauF/+ B cells (Fig. 3A). The Rhau WT and RhauF/F alleles were detected in the CD23cre+RhauF/+ and RhauF/F control cells at 2.6kb and 2.2kb, respectively (Fig. 3A; Lai et al., 2012).
CD23-cre primers were used to detect the CD23-cre transgene in the CD23-cre+RhauF/F and the
CD23-cre+RhauF/+ B cells; however, no amplicon was observed in the WT and RhauF/F B cells (Fig.
3B). Furthermore, RHAU was not detected at 115KD in the CD23-cre+RhauF/F B cells on an
immunoblot (Fig. 3C). Together, these data suggest that the decreased in vitro CSR to IgG1 in
the CD23-cre+RhauF/F B cells was due to the loss of RHAU expression.
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Figure 3. PCR genotyping for Rhau floxed alleles and immunoblot for RHAU protein expression.
(A) PCR genotyping detects the WT, floxed, and deleted Rhau alleles at 2.6kb, 2.2kb, and 1.5kb,
respectively. The 1kb ladder is from New England Biolabs.
(B) PCR genotyping detects the CD23-cre transgene in the positive (+) control, CD23-cre+RhauF/F, and
the CD23-cre+RhauF/+ B cells.
(C) Immunoblot shows the absence of RHAU at 115KD in the CD23-cre+RhauF/F B cells. AID and tubulin
were used as loading controls. The sets of B cells used for this experiment are different from (A) and
(B). This is unpublished data from Simin Zheng.

Decreased Ig titers in CD23-cre+RhauF/F mice
To determine whether deletion of Rhau in CD23-cre+RhauF/F B cells decreases switched Ig
isotypes in vivo, we collected sera from CD23-cre+RhauF/F and control mice before (day 0) and
after immunization with NP-CGG (day 7 and day 21). On day 10 after the first immunization, the
mice received a second dose of NP-CGG. ELISAs were performed to measure IgM, IgG1, IgA, and
IgG3 titers in the sera. IgM titers increased from day 0 to day 21 in the CD23-cre+RhauF/F mice
and were comparable to the IgM titers detected in the CD23-cre+RhauF/+ and RhauF/F control
mice (Fig. 4A), which suggests that antibody secretion and plasma cell formation were not
altered in the CD23-cre+RhauF/F mice (Choi et al., 2019). IgG1 titers were not detected in the
CD23-cre+RhauF/F mice on days 0 and 7 (Fig. 4B). A low IgG1 concentration (79.8 µg/mL) was
observed on day 21 in the CD23-cre+RhauF/F mice (Fig. 4B). From day 0 to day 21, IgG1 titers
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remained lower in the CD23-cre+RhauF/F mice as compared to the CD23-cre+RhauF/+ and RhauF/F
control mice (Fig. 4B). We were expecting the IgG1 titers in the CD23-cre+RhauF/+ and RhauF/F
sera to remain unchanged from day 0 to day 7, and peak on day 21; however, a decrease in
titers was observed on day 7 (Fig. 4B). The significance of this decrease will be examined in
future experiments. IgA titers were detected from day 0 to day 21 in the CD23-cre+RhauF/F mice,
remained constant across the days, and were inconsistent with the IgG1 titers detected in the
CD23-cre+RhauF/Fmice (Fig. 4B, 4C). IgA is mainly synthesized and secreted in mucus
membranes while IgG1 is the main Ig secreted in serum, which could explain the discrepancy
between the IgA and IgG1 titers in the CD23-cre+RhauF/F sera (Murphy et al., 2008).
Furthermore, the IgA titers were also lower in the CD23-cre+RhauF/F mice as compared to the
CD23-cre+RhauF/+ and RhauF/F control mice, a phenotype that was predicted with deletion of
Rhau in the CD23-cre+RhauF/F mouse B cells (Fig. 4C). We were expecting the IgA titers to
remain constant from day 0 to day 21 in the CD23-cre+RhauF/+ and RhauF/F control mice;
however, variations were observed in the IgA titers (Fig. 4C). Further experiments will
determine the significance of these variations. IgG3 antibodies were detected and peaked on
day 21 in the CD23-cre+RhauF/F mice and were lower from day 0 to day 21 compared to the
CD23-cre+RhauF/+ and RhauF/F control mice (Fig. 4D). IgG3, like IgG1 is mainly secreted in serum
(Grey et al., 1971). IgG1, IgA, and IgG3 titers remained lower in the CD23-cre+RhauF/F mice
compared to the titers measured in the CD23-cre+RhauF/+ and RhauF/F control mice from day 0
to day 21 indicating that in vivo CSR is also impaired in the CD23-cre+RhauF /F mice.
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C.

B.

D.

Figure 4. Decreased Ig titers in the CD23-cre+RhauF/F mice.
(A) Comparable IgM titers observed from day 0 to day 21 in the experimental CD23-cre+RhauF/F mice
and the CD23-cre+RhauF/+ and RhauF/F control mice.
(B-D) Decreased IgG1, IgA, and IgG3 observed in the CD23-cre+RhauF/F mice from day 0 to day 21 as
compared to the CD23-cre+RhauF/+ and RhauF/F control mice.

Discussion
In this research study, we report that RNA helicase RHAU plays a role in CSR. We hypothesized
that deletion of Rhau in B cells would result in decreased CSR. We first tested this hypothesis in
vitro using Aidcre/+RhauF/F B cells. CSR in the Aidcre/+RhauF/F B cells was comparable to WT B cells
(Fig. 1A, 1B), and suggested incomplete Rhau deletion in these cells. This result would be
consistent with a previous report, which showed lack of serine/threonine phosphatase (Pp4)
deletion in Aidcre/+Pp4F/F B cells, while Pp4 deletion was observed in CD23cre/+Pp4F/F B cells (Chen
et al., 2019). These observations suggested that the Aid promoter may not be efficiently
expressing the Cre recombinase in B cells. The WT CSR observed in the Aidcre/+RhauF/F B cells
(Fig. 1A, 1B), indicates that in vitro activation of the Aid promoter may not drive sufficient
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expression of the Cre recombinase and the subsequent deletion of the RhauF/F alleles in B cells
(Muramatsu et al., 2000). This hypothesis could be tested in a promoter-GFP fusion experiment
where we would compare the strength of the activated Aid promoter to the CD23 promoter,
which is constitutively activated in mature B cells (Carsetti et al., 1995). We could measure the
level of GFP in B cells with a CD23promoter-GFP or AIDpromoter-GFP expression construct. A
significant decrease in GFP fluorescence in AIDpromoter-GFP B cells as compared to
CD23promoter-GFP B cells would indicate that the Aid promoter does not drive sufficient
expression of Cre recombinase. Additionally, genotyping experiments need to be performed to
demonstrate the inadequate deletion of the RhauF/F alleles in Aidcre/+RhauF/F B cells.
Because CD23 is constitutively expressed in mature B cells (Carsetti et al., 1995), we decided to
investigate the role of RHAU in CSR using the CD23-cre transgene to delete RhauF/F in B cells.
We reasoned that the CD23 promoter could efficiently delete RhauF/F before the B cells
undergo CSR. Our FACS analysis revealed a 2-fold decrease for in vitro CSR to IgG1 in the CD23cre+RhauF/F B cells as compared to the CD23-cre+RhauF/+ and RhauF/F control cells (Fig. 2),
suggesting that deletion of Rhau in the CD23-cre+RhauF/F B cells accounts for the decrease
switching to IgG1. Our PCR analysis detected the deleted RhauF/F alleles at 1.5kb in the CD23cre+RhauF/F B cells (Fig. 3A), confirming that the decrease in vitro CSR to IgG1 observed in the
CD23-cre+RhauF/F B cells is a result of Rhau deletion in these cells. Furthermore, RHAU was not
detected at 115kD on an immunoblot in the CD23-cre+RhauF/F B cells (Fig. 3C), which validates
that the decrease in vitro switching to IgG1 in the CD23-cre+RhauF/F B cells is a consequence of
loss of RHAU expression. These results indicate that the decreased in vitro CSR observed in the
CD23-cre+RhauF/F B cells was likely due to loss of the Rhau gene and RHAU protein expression.
The residual in vitro switching observed with loss of RHAU suggests that other factors may
regulate CSR. DHX9 is a known paralog of RHAU that can also bind and unwind G4 RNA
transcripts (Murat et al., 2018). The residual in vitro switching in the CD23-cre+Rhau/F B cells
may result from DHX9 activity. Further experiments that delete or reduce Dhx9 in CD23cre+RhauF/F B cells using CRISPR/Cas9 or shRNA could address this hypothesis.
We subsequently examined how the absence of RHAU in B cells altered serum Ig titers. CD23cre+RhauF/F mice produced IgM from day 0 to day 21 as efficiently as the CD23-cre+RhauF/+ and
the RhauF/F control mice (Fig. 4A). IgM production and secretion was also observed in AIDdeficient mice which are unable to undergo CSR, indicating that plasma cell development and Ig
secretion were not impaired in CD23-cre+Rhau/F mice (Chen et al., 2019; Muramatsu et al.,
2000). We observed a decrease in IgG1, IgA, and IgG3 titers in the CD23-cre+RhauF/F mice as
compared to the CD23-cre+RhauF/+, and RhauF/F control mice (Fig. 4B-D). These findings are
consistent with the decrease in CSR to IgG1 in CD23-cre+RhauF/F B cells in vitro (Fig. 2). IgG1 was
almost undetectable in the CD23-cre+RhauF/F mice from day 0 to day 21 (Fig. 4B), while IgA and
IgG3 titers were detectable (Fig. 4C, 4D). IgA is mainly secreted in mucus membranes, and
secreted in small amount in sera (Murphy et al., 2008), which could explain the constant IgA
titers detected from day 0 to day 21 in the CD23-cre+RhauF/F sera. Furthermore, these data
suggest that RHAU is crucial for B cells to switch from IgM to IgG1, and that other RNA helicases
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compensate for the loss of RHAU in CD23-cre+RhauF/F B cells. Interestingly, a significant
decrease in IgG3 and IgA titers was observed in conditional knockout of Ddx1 in mouse B cells
(Ribeiro de Almeida et al., 2018). DDX1, like RHAU, binds and unwinds G4 RNA transcripts
(Ribeiro de Almeida et al., 2018, Sauer et al., 2019). RHAU and DDX1 may function redundantly
to regulate CSR to IgA and IgG3, and thus DDX1 generates the low IgA and IgG3 titers in the
CD23-cre+RHAUF/F mice. Additional experiments to delete or knock-down Ddx1 in CD23cre+RhauF/F B cells could address this hypothesis. Interestingly, RHAU and DDX1 form a helicase
complex with DDX21 (Zhang et al., 2011), suggesting that RHAU may interact with both DDX1
and DDX21 to regulate CSR. Further studies are needed to analyze whether loss of all three
helicases in B cells causes a complete loss of CSR.
RHAU functions in cell proliferation and differentiation. Deletion of Rhau causes a
developmental block in spermatogenesis in mouse testis, meiosis initiation arrest, and elevated
cell apoptosis (Gao et al., 2015). Rhau ablation in the hematopoietic system results in a
developmental defect in proerythroblasts (Lai et al., 2012). Additionally, defective proliferation
and impaired muscle regeneration has been observed with the deletion of Rhau in satellite cells
(Chen et al., 2020). These reports suggest that RHAU may also regulate B cell proliferation or
development, and that the decrease CSR observed in the CD23-cre+RhauF/F B cells may be a
result of impaired cell proliferation and development. A carboxyfluorescein succinimidyl ester
(CFSE) cell proliferation assay could reveal whether the decreased switching observed in the
RhauD/D B cells results from growth arrest in these cells (Quah & Parish, 2010). Furthermore,
RHAU regulates the transcription of genes whose promoters contain G-quadruplex motifs (Lai
et at., 2012). Thus, RHAU may regulate transcription of the S regions, which are deaminated by
AID and required for AID localization to the S region DNA (Zheng et al., 2015). Deletion of Rhau
in B cells may result in impaired S transcripts and decreased CSR. A RT-qPCR analysis could
reveal whether the decreased CSR observed in the CD23-cre+RHAUF/F B cells results from
decreased production of S transcripts.
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Appendices

Appendix Figure 1. Gating strategy and staining controls to select Aidcre/+RhauF/F B cells positive for IgG1.
First row shows the gating for the unstained cells. Second row shows the gating for the DAPI single stained
(DAPIss) cells. Third row shows the gating for the APC single stained (APCss) cells.
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Appendix Figure 2. Gating strategy and staining controls to select the CD23-cre+RhauF/F B cells positive
for IgG1.
First row shows the gating for the unstained cells. Second row shows the gating for the DAPI single
stained (DAPIss) cells. Third row shows the gating for the APC single stained (APCss) cells.
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Appendix Figure 3. FACS data showing decreased switching to IgG1 in the CD23-cre+RhauF/F B cells.
Data shows gating of IgG1 positive CD23-cre+RhauF/F B cells. Top data obtained from Simin Zheng.
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